Risk for Preterm Birth Stops Maternal RSV Vaccine Trial Risk for Preterm Birth Stops Maternal RSV Vaccine Trial

With a maternal vaccine already on the market to protect newborns from RSV, the outlook for another looked promising, but latest phase 3 trial of a new candidate is now halted over safety concerns.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Infectious Diseases Source Type: news